Print

Healthcare Services Insights

L.E.K. Consulting

The CDC estimates that nearly 80 people die of opioid overdose each day in the United States. Opioid overuse is a critical issue, and the need for interventions is becoming an urgent priority for many health systems. In this Executive Insights, we review how L.E.K. Consulting worked with Utah-based Intermountain Healthcare to develop a comprehensive pain management strategy.

Volume XIX, Issue 53 | August 16, 2017 | By: Harsha Madannavar, Todd Clark, Joseph Johnson

Most data-driven healthcare IT (HCIT) providers aren’t going to survive. Their business models are at serious risk of failure in the next three to five years. To beat those odds, they need to evolve dramatically, and fast, to a point where they are not selling data at all. This Executive Insights examines ways that data providers are making the move from data provider to data analytics services.

Volume XIX, Issue 43 | July 10, 2017 | By: Ben Faircloth

In this Executive Insights, L.E.K. Consulting explores how the use of technology to increase efficiency and enhance quality is transforming the pharma sector. The challenge will be to determine the most effective route to offer truly differentiated services.

Volume XIX, Issue 41 | June 29, 2017 | By: Arnaud Sergent, Serge Hovsepian

In this Executive Insights, L.E.K. Consulting examines how homecare providers can address pressure to reduce healthcare costs while maintaining profitability by consolidating local market share in their core segments and improving operational efficiencies.

Volume XIX, Issue 35 | June 6, 2017 | By: Todd Clark

In the midst of the continuing uncertainty related to the “repeal and replace” of the Affordable Care Act (ACA), those with an eye on Medicaid programs are bracing for reduced funding in some form, whether or not they manifest in block (per capita) payments. This Executive Insights examines the range of mechanisms by states to incentivize MCO performance and includes case studies from the District of Columbia, Ohio and South Carolina.

Volume XIX, Issue 25 | April 17, 2017 | By: Bill Frack, Kevin Grabenstatter

UnitedHealthcare’s recently announced acquisition of Surgical Care Affiliates (SCA) represents the latest signal that the $30 billion ambulatory surgery center (ASC) segment is moving to the forefront of the rapidly evolving healthcare market. In this Executive Insights, L.E.K. Consulting looks at the various factors favoring further share gains for these value-oriented care facilities.

Volume XIX, Issue 18 | March 8, 2017 | By: Monish Rajpal

The ongoing transformation of traditional healthcare has compelled providers to restructure practice locations, medical affiliations and processes in order to maintain profitability without ceding market share, care quality or convenience. In this Executive Insights, we look into current outpatient trends and highlight a number of “hot topic” practices that come up for discussion frequently.

Volume XIX, Issue 13 | February 13, 2017 | By: Jonathan Sparey

The NHS is part of the fabric of Britain. However, increasing pressures on the system have resulted in an NHS which is now in crisis. Private healthcare providers have the potential to help meet the country’s growing healthcare needs by providing critical and complementary support to core NHS services. This Executive Insights examines the changing nature of the U.K.’s healthcare needs and details five key challenges private providers need to address if they are to become of greater strategic importance.

Analysis 1 | January 25, 2017 | By: Alex Evans, Chris Randall

The 2016 Health & Wellness Study examines consumer spending preferences for nutritional supplements, personal care and healthy grocery products among Millennials, Gen X and Boomers. The study looks at category engagement, drivers of channel selection and, the potential for subscription services, as well as the success factors for private-label products.

Volume XIX, Issue 1 | January 5, 2017 | By: Clay Heskett, Helen Chen, Peter Rosenorn, David Barrow

Developing therapeutics and medical devices for global healthcare markets remains a risky proposition. The medical innovations now coming to market are remarkable and reflect the reaction of healthcare companies towards innovation a decade ago. Globally, the biopharma and medtech sectors are being shaped by four significant forces, which will determine the success factors for the next generation of healthcare products. In this Executive Insights, L.E.K. examines each of the key forces driving change.

Pages